Showing results (431-440 of 606) with videos related to
Sort By:
Pageof 61
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 7, 2002
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaMichael A Kass, Dale K Heuer, Eve J Higginbotham, et al.JACC. Cardiovascular Imaging|July 16, 2011
Influence of atrial function and mechanical synchrony on LV hemodynamic status in heart failure patients on resynchronization therapyHsin-Yueh Liang, Alan Cheng, Kuan-Cheng Chang, et al.Ophthalmology|November 11, 2006
Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension, , Mae O Gordon, et al.American Journal of Ophthalmology|May 22, 2026
Ocular Hypertension Treatment Study: Effect of time after incident glaucoma on OCT optic nerve head and macula measurementsEvan Walker, Christopher Bowd, Sonia Jain, et al.Ophthalmology|September 26, 2006
Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment StudyDonald L Budenz, Douglas R Anderson, William J Feuer, et al.The Annals of Thoracic Surgery|July 1, 1993
Pressure-volume analysis of changes in cardiac function in chronic cardiomyoplastyP W Cho, H R Levin, W E Curtis, et al.Circulation|May 1, 1995
Reverse remodeling from cardiomyoplasty in human heart failure. External constraint versus active assistD A Kass, K L Baughman, P H Pak, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 29, 2002
An increase in the myocardial PCr/ATP ratio in GLUT4 null miceRobert G Weiss, John C Chatham, Dimitrios Georgakopolous, et al.Circulation|December 13, 2006
Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) TrialLeslie A Saxon, Michael R Bristow, John Boehmer, et al.Circulation Research|December 17, 2005
Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent pathwayMarco Mongillo, Carlo G Tocchetti, Anna Terrin, et al.Pageof 61